Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lung transplantation].

P Dartevelle1, P Vouhe, J Cerrina

  • 1Service de chirurgie thoracique et de transplantation cardio-vasculaire, Centre Marie-Lannelongue, Le Plessis-Robinson.

Nephrologie
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Controlled donation after circulatory death lung transplantation: Results of the French protocol including in situ abdominal normothermic regional perfusion and ex vivo lung perfusion.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2023
Same author

Lung transplantation for COVID-19-associated acute respiratory distress syndrome: The first French patient.

Respiratory medicine and research·2021
Same author

Klippel-Trenaunay syndrome as a rare cause of chronic thromboemboembolic pulmonary hypertension.

Respiratory medicine and research·2019
Same author

Chronic thromboembolic and pulmonary arterial hypertension share right ventricular and pulmonary artery CMR features.

Pulmonology·2019
Same author

[Pulmonary veno-occlusive disease].

Revue des maladies respiratoires·2018
Same author

Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism.

Thrombosis and haemostasis·2014
Same journal

Short-term effect of folic acid supplementation in renal transplant recipients and chronic kidney disease patients with comparable renal function impairment.

Nephrologie·2004
Same journal

[Acute renal failure and 2,8-dihydroxyadeninuria].

Nephrologie·2004
Same journal

[Phototherapy and hemodialysis pruritus].

Nephrologie·2004
Same journal

[Pregnancy and hemodialysis].

Nephrologie·2004
Same journal

[Role of dietary fibers in the nutritional management of chronic renal failure].

Nephrologie·2004
Same journal

[Abstracts of the VI Meeting of the Society of Nephrology and of the Francophone Society of Dialysis. Marseille, France, 28 September-1 October 2004].

Nephrologie·2004
See all related articles

Lung transplantation offers three methods: single lung, double lung, or heart-lung transplant. Indications for each transplant type and managing post-transplant complications like rejection remain challenges.

Area of Science:

  • Cardiovascular and Respiratory Surgery
  • Transplantation Medicine
  • Immunology

Context:

  • Pulmonary transplantation encompasses single lung, double lung, and heart-lung procedures.
  • Cardiopulmonary transplantation is indicated for pulmonary arterial hypertension.
  • Clear indications for each transplant type are not yet established.

Purpose:

  • To review the current landscape of pulmonary transplant procedures.
  • To highlight challenges in transplant indications and postoperative management.
  • To discuss long-term complications and limitations in donor availability.

Summary:

  • Pulmonary transplantation includes single lung, double lung, and heart-lung transplants, with the latter indicated for pulmonary arterial hypertension.

Related Experiment Videos

  • Postoperative mortality is approximately 30% due to rejection and infections.
  • Long-term risks include obliterative bronchiolitis from chronic rejection, and donor scarcity limits development.
  • Impact:

    • Clarifying transplant indications can optimize patient selection and outcomes.
    • Addressing postoperative complications is crucial for reducing mortality.
    • Overcoming donor limitations is essential for advancing lung transplantation and improving patient survival.